-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
IGC Pharma, Inc. quarterly/annual Cost of Revenue history and growth rate from 2010 to 2023.
- IGC Pharma, Inc. Cost of Revenue for the quarter ending June 30, 2024 was $109K, a 63.7% decline year-over-year.
- IGC Pharma, Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $421K, a 39.8% decline year-over-year.
- IGC Pharma, Inc. annual Cost of Revenue for 2023 was $612K, a 30.5% increase from 2022.
- IGC Pharma, Inc. annual Cost of Revenue for 2022 was $469K, a 131% increase from 2021.
- IGC Pharma, Inc. annual Cost of Revenue for 2021 was $203K, a 74.1% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)